CSL Aktie

 

Can CSL's improving outlook justify its higher share price? The post CSL shares just fell 5% after a strong rally. Is the recovery losing steam? appeared first on The Motley Fool Australia....

Phase 3 study demonstrates benefits of the first influenza vaccine to combine three proven approaches to enhancing protection for older adults in a single vaccine. MAIDENHEAD, United Kingdom, Sept. 10, 2026 /PRNewswire/ -- CSL Seqirus, a business of CSL (ASX: CSL; USOTC: CSLLY), today......

The biotech giant has been on a tear. Is it too late to invest? Let's find out. The post Higher or lower: Where are CSL shares going next? appeared first on The Motley Fool Australia....

CSL gains from strong construction demand, segment growth and shareholder returns, though rising costs, margin pressure and debt pose risks....

A $75 gap between the bulls and the bears. The post CSL shares are up 90%. Brokers can't agree what happens next appeared first on The Motley Fool Australia....

CSL's recovery could deliver more upside or another sharp reversal. The post CSL shares are up 90%. How much higher can they go? appeared first on The Motley Fool Australia....

Brokers have given their latest verdicts on these ASX shares. The post Buy, hold, sell: BHP, CSL, CBA shares appeared first on The Motley Fool Australia....

Brokers see better opportunities beyond CSL shares. The post Forget CSL shares. 3 ASX healthcare stocks with bigger upside appeared first on The Motley Fool Australia....

After plunging to a nine-year low in June, CSL shares have gone gangbusters. The post $10,000 invested in CSL shares in June is now worth… appeared first on The Motley Fool Australia....

SSUMY vs. CSL: Which Stock Is the Better Value Option?...

CSL has a strong track record of increasing its dividend payout over time. The post If I invest $10,000 in CSL shares, what passive income will I earn in FY27? appeared first on The Motley Fool Australia....

The healthcare giant is no longer dirt cheap, but let's find out if the current valuation leaves room for long-term investors. The post Are CSL shares still cheap after almost doubling since June? appeared first on The Motley Fool Australia....

The rebound of healthcare stocks looks promising, but proving the recovery is real remains. The post CSL led the ASX healthcare shares rebound. Can it continue? appeared first on The Motley Fool Australia....

Can CSL's improving fundamentals justify the optimism now priced into shares? The post CSL shares are up 94% from their low. What are brokers forecasting next? appeared first on The Motley Fool Australia....

Not only have CSL shares surged 91% since June, but the final dividend payout is still up for grabs. Though not for long! The post Looking to bank the upcoming CSL dividend? You better hurry! appeared first on The Motley Fool Australia....

They include CSL, Mineral Resources, Genesis Minerals, Perpetual, Hub24, and WiseTech shares. The post 40 ASX shares with ex-dividend dates next week appeared first on The Motley Fool Australia....

Find insight on Insilico, CSL, Sonic Healthcare and more in the latest Market Talks covering health care....

Investors sent CSL shares rocketing 39% in August. But why? The post How CSL shares skyrocketed 39% in August appeared first on The Motley Fool Australia....

Brokers retained a positive view on CSL, BHP, Flight Centre, NextDC, and other shares post-results. The post 11 ASX 200 shares with reaffirmed buy ratings post-results appeared first on The Motley Fool Australia....

Find insight on Novartis, CSL, Fortis Healthcare and more in the latest Market Talks covering health care....